hIAPP forms toxic oligomers in plasma

Chem Commun (Camb). 2018 May 24;54(43):5426-5429. doi: 10.1039/c8cc03097a.

Abstract

In diabetes, hyperamylinemia contributes to cardiac dysfunction. The interplay between hIAPP, blood glucose and other plasma components is, however, not understood. We show that glucose and LDL interact with hIAPP, resulting in β-sheet rich oligomers with increased β-cell toxicity and hemolytic activity, providing mechanistic insights for a direct link between diabetes and cardiovascular diseases.

MeSH terms

  • Blood Glucose / metabolism*
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Cholesterol, LDL / blood
  • Cholesterol, LDL / pharmacology*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Humans
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology
  • Islet Amyloid Polypeptide / blood
  • Islet Amyloid Polypeptide / pharmacology*

Substances

  • Blood Glucose
  • Cholesterol, LDL
  • Islet Amyloid Polypeptide